- Home
- MTR vs ICU Comparison
MTR vs ICU Comparison
Compare MTR & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTR
- ICU
- Stock Information
- Founded
- MTR 1979
- ICU 2018
- Country
- MTR United States
- ICU United States
- Employees
- MTR N/A
- ICU N/A
- Industry
- MTR Oil & Gas Production
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- MTR Energy
- ICU Health Care
- Exchange
- MTR Nasdaq
- ICU Nasdaq
- Market Cap
- MTR 9.4M
- ICU 10.4M
- IPO Year
- MTR N/A
- ICU N/A
- Fundamental
- Price
- MTR $5.10
- ICU $1.27
- Analyst Decision
- MTR
- ICU
- Analyst Count
- MTR 0
- ICU 0
- Target Price
- MTR N/A
- ICU N/A
- AVG Volume (30 Days)
- MTR 5.6K
- ICU 144.4K
- Earning Date
- MTR 01-01-0001
- ICU 05-14-2025
- Dividend Yield
- MTR 3.24%
- ICU N/A
- EPS Growth
- MTR N/A
- ICU N/A
- EPS
- MTR 0.23
- ICU N/A
- Revenue
- MTR $668,826.00
- ICU $428,000.00
- Revenue This Year
- MTR N/A
- ICU $754.07
- Revenue Next Year
- MTR N/A
- ICU $100.09
- P/E Ratio
- MTR $22.52
- ICU N/A
- Revenue Growth
- MTR N/A
- ICU N/A
- 52 Week Low
- MTR $4.70
- ICU $1.11
- 52 Week High
- MTR $8.97
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- MTR 47.75
- ICU 51.67
- Support Level
- MTR $4.93
- ICU $1.12
- Resistance Level
- MTR $5.11
- ICU $1.34
- Average True Range (ATR)
- MTR 0.10
- ICU 0.07
- MACD
- MTR 0.02
- ICU 0.01
- Stochastic Oscillator
- MTR 68.53
- ICU 68.18
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.